140 related articles for article (PubMed ID: 3927462)
1. [Evolution of Paget's disease of bone during and after treatment with small doses of disodium etidronate (EHDP)].
Reginster JY; Gritten C; Diverse P; Hauwaert C; Halleux R; Franchimont P
Rev Med Liege; 1985 May; 40(10):417-22. PubMed ID: 3927462
[No Abstract] [Full Text] [Related]
2. Small doses of etidronate (EHDP) and Paget's disease: meaning and importance of the decrease in plasmatic 25(OH)D3.
D'Amore M; Carrozzo M; Cantatore FP; Scagliusi P; Pipitone V
Panminerva Med; 1984; 26(1):13-7. PubMed ID: 6233523
[No Abstract] [Full Text] [Related]
3. [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].
Jung A; Mermillod B; Schenk R; Courvoisier B; Burkhardt P; Epiney J; Fleisch
Schweiz Med Wochenschr; 1976 Nov; 106(48):1667-73. PubMed ID: 827810
[TBL] [Abstract][Full Text] [Related]
4. Review of fracture experience during treatment of Paget's disease of bone with etidronate disodium (EHDP).
Johnston CC; Altman RD; Canfield RE; Finerman GA; Taulbee JD; Ebert ML
Clin Orthop Relat Res; 1983; (172):186-94. PubMed ID: 6401608
[No Abstract] [Full Text] [Related]
5. [Treatment of Paget's disease with the combined administration of calcitonin and disodium etidronate].
Ghiringhelli G; Fogel M; Varela de Rodríguez J; Casco C; Mautelén C; Nusimovich B
Medicina (B Aires); 1982; 42(1):16-20. PubMed ID: 6813634
[No Abstract] [Full Text] [Related]
6. Etidronate disodium for Paget's disease.
Med Lett Drugs Ther; 1978 Sep; 20(18):78-9. PubMed ID: 99647
[No Abstract] [Full Text] [Related]
7. Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP).
Rashid M; Khairi A; Johnston C
Clin Orthop Relat Res; 1977; (127):94-105. PubMed ID: 410576
[No Abstract] [Full Text] [Related]
8. Spontaneous fractures of uninvolved bones in patients with Paget's disease during unduly prolonged treatment with disodium etidronate (EHDP).
Mautalen C; Gonzalez D; Blumenfeld EL; Santini Araujo E; Schajowicz F
Clin Orthop Relat Res; 1986 Jun; (207):150-5. PubMed ID: 3087670
[TBL] [Abstract][Full Text] [Related]
9. [Pseudosarcomatous osteolysis in a Paget's disease patient treated with disodium etidronate (EHDP)].
Rondier J; Huchet B; Cayla J
Rev Rhum Mal Osteoartic; 1984 Jan; 51(1):49-54. PubMed ID: 6420876
[No Abstract] [Full Text] [Related]
10. [Osteolysis, then fracture of the femur in a Paget's disease patient treated with high-dose disodium etidronate].
Pinel B; Cambon C; Thomine JM; Cauvin M; Daragon A; Deshayes P
Rev Rhum Mal Osteoartic; 1984; 51(7-8):417-8. PubMed ID: 6436959
[No Abstract] [Full Text] [Related]
11. [Therapeutic sequences calcitonin-EHDP and EHDP-calcitonin in Paget's disease. Histological and biological study].
Eisinger J; Laponche AM; Ouaniche J
Rev Rhum Mal Osteoartic; 1986 Mar; 53(3):183-5. PubMed ID: 3085204
[No Abstract] [Full Text] [Related]
12. [Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)].
Alexandre C; Chapuy MC; Bressot C; Vignon E; Arlot M; Mathieu L; Edouard C; Johnston CC; Meunier PJ
Nouv Presse Med; 1980 Nov; 9(45):3429-33. PubMed ID: 6777752
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of sodium etidronate in the treatment of Paget's disease of bone. Osteitis deformans.
Stein I; Shapiro B; Ostrum B; Beller ML
Clin Orthop Relat Res; 1977; (122):347-58. PubMed ID: 402246
[TBL] [Abstract][Full Text] [Related]
14. Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans).
Altman RD; Johnston CC; Khairi MR; Wellman H; Serafini AN; Sankey RR
N Engl J Med; 1973 Dec; 289(26):1379-84. PubMed ID: 4201876
[No Abstract] [Full Text] [Related]
15. Results of prolonged treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP).
De Vries HR; Bijvoet OL
Neth J Med; 1974; 17(6):281-98. PubMed ID: 4280525
[No Abstract] [Full Text] [Related]
16. Quantitative bone histology in Paget's disease of bone: influence of sodium etidronate (EHDP) therapy.
Khairi MR; Meunier P; Edouard C; Courpron P; Bernard J; DeRosa GP; Johnston CC
Calcif Tissue Res; 1977 May; 22 Suppl():355-8. PubMed ID: 410484
[No Abstract] [Full Text] [Related]
17. Influence of disodium etidronate on Paget's disease of bone.
Muir HG; Schabort I; Hough FS
S Afr Med J; 1987 Oct; 72(7):470-2. PubMed ID: 3116683
[TBL] [Abstract][Full Text] [Related]
18. Effective short term treatment of Paget's disease with oral etidronate.
Preston CJ; Yates AJ; Beneton MN; Russell RG; Gray RE; Smith R; Kanis JA
Br Med J (Clin Res Ed); 1986 Jan; 292(6513):79-80. PubMed ID: 3080099
[TBL] [Abstract][Full Text] [Related]
19. [Etidronic acid therapy in Paget's disease of bone].
Holz G; Delling G; Ziegler R
Dtsch Med Wochenschr; 1983 Dec; 108(51-52):1954-8. PubMed ID: 6418505
[TBL] [Abstract][Full Text] [Related]
20. [EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of polyosseous Paget disease].
Kovarik J; Niebauer B; Woloszczuk W; Frühwald F; Kolbe H
Wien Klin Wochenschr; 1985 Mar; 97(7):311-5. PubMed ID: 3922124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
